Revvity, Inc. (RVTY) Financials
RVTY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 13.4 billion | 5.6 billion |
| 2023-12-31 | 13.6 billion | 5.7 billion |
| 2023-09-30 | 13.4 billion | 5.7 billion |
| 2023-06-30 | 14.2 billion | 6.3 billion |
RVTY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | 129.7 million | 11.7 million |
| 2023-12-31 | 172.5 million | 7.2 million |
| 2023-09-30 | -55.8 million | 10.7 million |
| 2023-06-30 | -149.3 million | 13.6 million |
RVTY Net Income
| Date | Net Income |
|---|---|
| 2024-03-31 | 28.7 million |
| 2023-12-31 | 63.6 million |
| 2023-09-30 | 32.5 million |
| 2023-06-30 | 58.6 million |
RVTY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 1.7 billion | - | - |
| 2023-12-31 | 1.6 billion | - | 165.7 million |
| 2023-09-30 | 1.4 billion | - | 133.9 million |
| 2023-06-30 | 2.1 billion | 3.9 billion | 144.2 million |
RVTY Shares Outstanding
RVTY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 17.8 million | 50.4 million | - | - |
| 2023-12-31 | 24.1 million | 49.6 million | 251.8 million | - |
| 2023-09-30 | 22.4 million | 53.0 million | 250.7 million | -497000 |
| 2023-06-30 | 13.9 million | 57.3 million | 269.3 million | -2.3 million |
RVTY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 649.9 million | 386.1 million |
| 2023-12-31 | 695.9 million | 402.0 million |
| 2023-09-30 | 670.7 million | 298.2 million |
| 2023-06-30 | 709.1 million | 306.7 million |
RVTY
Price: $110.23
Dividend Yield: 0.00%
Forward Dividend Yield: 0.25%
Payout Ratio: 19.44%
Dividend Per Share: 0.28 USD
Earnings Per Share: 1.47 USD
P/E Ratio: 71.46
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 12.9 billion
Average Dividend Frequency: 4
Years Paying Dividends: 42